Global Healthcare Contract Research Outsourcing Market

Healthcare Contract Research Outsourcing Comprehensive Study by Service (Clinical Trial Service, Regulatory Service, Clinical Data Management & Biometrics, Medical Writing, Site Management Protocol, Pharmacovigilance, Other), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic Institutes & Government organizations), Therapeutic Area (Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Immunology, Infectious Diseases, Rare Diseases, Medical Devices, Other) Players and Region - Global Market Outlook to 2026

Healthcare Contract Research Outsourcing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
It is a trend for pharmaceutical enterprises to contract third parties to conduct their clinical trials in order to test their drugs. This trend is stated to as ‘outsourcing’, and the companies that carry out the work are known as ‘contract research organizations’ (CROs). Furthermore, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low and middle income nations. This trend is also called ‘offshoring’. It is widely established that the offshoring of clinical trials to these regions should be examined from an ethical perspective because of the vulnerability of the trial population.This growth is primarily driven by Growing Number of Clinical Trials Along With Increasing R&D Expenditure and Rising Efforts for Optimization of Costs and Development Time for Drug Development.

Globally, a noticeable market trend is evident Rising Demand for Specialized Testing Services. Major Players, such as Syneos Health (United States), PAREXEL International (United States), ICON Plc (Ireland), PRA Health Sciences, Inc. (United States), Charles River Laboratories (United States), Laboratory Corporation of America Holdings (United States), IQVIA (United States), Medpace (United States), Pharmaceutical Product Development, LLC (United States) and Envigo (United Kingdom) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On Apr 17, 2019 - LabCorp and Envigo has signed innovative agreement to expand Covance's nonclinical drug development capabilities and create an independent research models provider.
On Mar 11, 2019 - Envigo, a leading provider of non-clinical contract research services and research models, has announced the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.

Regulatory Insights:
The FDA defines each participant’s responsibilities within cooperative manufacturing agreements based on the Code of federal Regulation. Manufacture is defined as “the responsible entity to legally manufacturing a drug”. Therefore, license holders are responsible for the whole process, but based on the contract, Sponsors delegate some of responsibilities. The license holder should be ensured about CRO’s compliance and report any changes in the products. License holders are also responsible, helping ensure that CROs comply with federal regulations.

Market Drivers
  • Growing Number of Clinical Trials Along With Increasing R&D Expenditure
  • Rising Efforts for Optimization of Costs and Development Time for Drug Development

Market Trend
  • Rising Demand for Specialized Testing Services

Restraints
  • Shortage of Skilled Professionals

Opportunities
Growing Favorable Government Support
Challenges
Intense Competition in the CRO Services

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Healthcare Contract Research Outsourcing Study Sheds Light on
— The Healthcare Contract Research Outsourcing Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Healthcare Contract Research Outsourcing industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Healthcare Contract Research Outsourcing industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Service
  • Clinical Trial Service
  • Regulatory Service
  • Clinical Data Management & Biometrics
  • Medical Writing
  • Site Management Protocol
  • Pharmacovigilance
  • Other

By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Academic Institutes & Government organizations

By Therapeutic Area
  • Oncology/Hematology
  • CNS
  • CV/Metabolic
  • Respiratory
  • Immunology
  • Infectious Diseases
  • Rare Diseases
  • Medical Devices
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Clinical Trials Along With Increasing R&D Expenditure
      • 3.2.2. Rising Efforts for Optimization of Costs and Development Time for Drug Development
    • 3.3. Market Challenges
      • 3.3.1. Intense Competition in the CRO Services
    • 3.4. Market Trends
      • 3.4.1. Rising Demand for Specialized Testing Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare Contract Research Outsourcing, by Service, End User, Therapeutic Area and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Healthcare Contract Research Outsourcing (Value)
      • 5.2.1. Global Healthcare Contract Research Outsourcing by: Service (Value)
        • 5.2.1.1. Clinical Trial Service
        • 5.2.1.2. Regulatory Service
        • 5.2.1.3. Clinical Data Management & Biometrics
        • 5.2.1.4. Medical Writing
        • 5.2.1.5. Site Management Protocol
        • 5.2.1.6. Pharmacovigilance
        • 5.2.1.7. Other
      • 5.2.2. Global Healthcare Contract Research Outsourcing by: End User (Value)
        • 5.2.2.1. Pharmaceutical Companies
        • 5.2.2.2. Biotechnology Companies
        • 5.2.2.3. Medical Device Companies
        • 5.2.2.4. Academic Institutes & Government organizations
      • 5.2.3. Global Healthcare Contract Research Outsourcing by: Therapeutic Area (Value)
        • 5.2.3.1. Oncology/Hematology
        • 5.2.3.2. CNS
        • 5.2.3.3. CV/Metabolic
        • 5.2.3.4. Respiratory
        • 5.2.3.5. Immunology
        • 5.2.3.6. Infectious Diseases
        • 5.2.3.7. Rare Diseases
        • 5.2.3.8. Medical Devices
        • 5.2.3.9. Other
      • 5.2.4. Global Healthcare Contract Research Outsourcing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Healthcare Contract Research Outsourcing (Price)
  • 6. Healthcare Contract Research Outsourcing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Syneos Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PAREXEL International (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ICON Plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PRA Health Sciences, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Charles River Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Laboratory Corporation of America Holdings (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. IQVIA (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medpace (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pharmaceutical Product Development, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Envigo (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Healthcare Contract Research Outsourcing Sale, by Service, End User, Therapeutic Area and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Healthcare Contract Research Outsourcing (Value)
      • 7.2.1. Global Healthcare Contract Research Outsourcing by: Service (Value)
        • 7.2.1.1. Clinical Trial Service
        • 7.2.1.2. Regulatory Service
        • 7.2.1.3. Clinical Data Management & Biometrics
        • 7.2.1.4. Medical Writing
        • 7.2.1.5. Site Management Protocol
        • 7.2.1.6. Pharmacovigilance
        • 7.2.1.7. Other
      • 7.2.2. Global Healthcare Contract Research Outsourcing by: End User (Value)
        • 7.2.2.1. Pharmaceutical Companies
        • 7.2.2.2. Biotechnology Companies
        • 7.2.2.3. Medical Device Companies
        • 7.2.2.4. Academic Institutes & Government organizations
      • 7.2.3. Global Healthcare Contract Research Outsourcing by: Therapeutic Area (Value)
        • 7.2.3.1. Oncology/Hematology
        • 7.2.3.2. CNS
        • 7.2.3.3. CV/Metabolic
        • 7.2.3.4. Respiratory
        • 7.2.3.5. Immunology
        • 7.2.3.6. Infectious Diseases
        • 7.2.3.7. Rare Diseases
        • 7.2.3.8. Medical Devices
        • 7.2.3.9. Other
      • 7.2.4. Global Healthcare Contract Research Outsourcing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Healthcare Contract Research Outsourcing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare Contract Research Outsourcing: by Service(USD Million)
  • Table 2. Healthcare Contract Research Outsourcing Clinical Trial Service , by Region USD Million (2015-2020)
  • Table 3. Healthcare Contract Research Outsourcing Regulatory Service , by Region USD Million (2015-2020)
  • Table 4. Healthcare Contract Research Outsourcing Clinical Data Management & Biometrics , by Region USD Million (2015-2020)
  • Table 5. Healthcare Contract Research Outsourcing Medical Writing , by Region USD Million (2015-2020)
  • Table 6. Healthcare Contract Research Outsourcing Site Management Protocol , by Region USD Million (2015-2020)
  • Table 7. Healthcare Contract Research Outsourcing Pharmacovigilance , by Region USD Million (2015-2020)
  • Table 8. Healthcare Contract Research Outsourcing Other , by Region USD Million (2015-2020)
  • Table 9. Healthcare Contract Research Outsourcing: by End User(USD Million)
  • Table 10. Healthcare Contract Research Outsourcing Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 11. Healthcare Contract Research Outsourcing Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 12. Healthcare Contract Research Outsourcing Medical Device Companies , by Region USD Million (2015-2020)
  • Table 13. Healthcare Contract Research Outsourcing Academic Institutes & Government organizations , by Region USD Million (2015-2020)
  • Table 14. Healthcare Contract Research Outsourcing: by Therapeutic Area(USD Million)
  • Table 15. Healthcare Contract Research Outsourcing Oncology/Hematology , by Region USD Million (2015-2020)
  • Table 16. Healthcare Contract Research Outsourcing CNS , by Region USD Million (2015-2020)
  • Table 17. Healthcare Contract Research Outsourcing CV/Metabolic , by Region USD Million (2015-2020)
  • Table 18. Healthcare Contract Research Outsourcing Respiratory , by Region USD Million (2015-2020)
  • Table 19. Healthcare Contract Research Outsourcing Immunology , by Region USD Million (2015-2020)
  • Table 20. Healthcare Contract Research Outsourcing Infectious Diseases , by Region USD Million (2015-2020)
  • Table 21. Healthcare Contract Research Outsourcing Rare Diseases , by Region USD Million (2015-2020)
  • Table 22. Healthcare Contract Research Outsourcing Medical Devices , by Region USD Million (2015-2020)
  • Table 23. Healthcare Contract Research Outsourcing Other , by Region USD Million (2015-2020)
  • Table 24. South America Healthcare Contract Research Outsourcing, by Country USD Million (2015-2020)
  • Table 25. South America Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 26. South America Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 27. South America Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 28. Brazil Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 29. Brazil Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 30. Brazil Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 31. Argentina Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 32. Argentina Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 33. Argentina Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 34. Rest of South America Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 35. Rest of South America Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 36. Rest of South America Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 37. Asia Pacific Healthcare Contract Research Outsourcing, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 39. Asia Pacific Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 40. Asia Pacific Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 41. China Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 42. China Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 43. China Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 44. Japan Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 45. Japan Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 46. Japan Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 47. India Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 48. India Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 49. India Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 50. South Korea Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 51. South Korea Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 52. South Korea Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 53. Taiwan Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 54. Taiwan Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 55. Taiwan Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 56. Australia Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 57. Australia Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 58. Australia Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 59. Rest of Asia-Pacific Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 62. Europe Healthcare Contract Research Outsourcing, by Country USD Million (2015-2020)
  • Table 63. Europe Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 64. Europe Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 65. Europe Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 66. Germany Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 67. Germany Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 68. Germany Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 69. France Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 70. France Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 71. France Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 72. Italy Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 73. Italy Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 74. Italy Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 75. United Kingdom Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 76. United Kingdom Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 77. United Kingdom Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 78. Netherlands Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 79. Netherlands Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 80. Netherlands Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 81. Rest of Europe Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 82. Rest of Europe Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 83. Rest of Europe Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 84. MEA Healthcare Contract Research Outsourcing, by Country USD Million (2015-2020)
  • Table 85. MEA Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 86. MEA Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 87. MEA Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 88. Middle East Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 89. Middle East Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 90. Middle East Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 91. Africa Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 92. Africa Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 93. Africa Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 94. North America Healthcare Contract Research Outsourcing, by Country USD Million (2015-2020)
  • Table 95. North America Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 96. North America Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 97. North America Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 98. United States Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 99. United States Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 100. United States Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 101. Canada Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 102. Canada Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 103. Canada Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 104. Mexico Healthcare Contract Research Outsourcing, by Service USD Million (2015-2020)
  • Table 105. Mexico Healthcare Contract Research Outsourcing, by End User USD Million (2015-2020)
  • Table 106. Mexico Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2015-2020)
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Healthcare Contract Research Outsourcing: by Service(USD Million)
  • Table 118. Healthcare Contract Research Outsourcing Clinical Trial Service , by Region USD Million (2021-2026)
  • Table 119. Healthcare Contract Research Outsourcing Regulatory Service , by Region USD Million (2021-2026)
  • Table 120. Healthcare Contract Research Outsourcing Clinical Data Management & Biometrics , by Region USD Million (2021-2026)
  • Table 121. Healthcare Contract Research Outsourcing Medical Writing , by Region USD Million (2021-2026)
  • Table 122. Healthcare Contract Research Outsourcing Site Management Protocol , by Region USD Million (2021-2026)
  • Table 123. Healthcare Contract Research Outsourcing Pharmacovigilance , by Region USD Million (2021-2026)
  • Table 124. Healthcare Contract Research Outsourcing Other , by Region USD Million (2021-2026)
  • Table 125. Healthcare Contract Research Outsourcing: by End User(USD Million)
  • Table 126. Healthcare Contract Research Outsourcing Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 127. Healthcare Contract Research Outsourcing Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 128. Healthcare Contract Research Outsourcing Medical Device Companies , by Region USD Million (2021-2026)
  • Table 129. Healthcare Contract Research Outsourcing Academic Institutes & Government organizations , by Region USD Million (2021-2026)
  • Table 130. Healthcare Contract Research Outsourcing: by Therapeutic Area(USD Million)
  • Table 131. Healthcare Contract Research Outsourcing Oncology/Hematology , by Region USD Million (2021-2026)
  • Table 132. Healthcare Contract Research Outsourcing CNS , by Region USD Million (2021-2026)
  • Table 133. Healthcare Contract Research Outsourcing CV/Metabolic , by Region USD Million (2021-2026)
  • Table 134. Healthcare Contract Research Outsourcing Respiratory , by Region USD Million (2021-2026)
  • Table 135. Healthcare Contract Research Outsourcing Immunology , by Region USD Million (2021-2026)
  • Table 136. Healthcare Contract Research Outsourcing Infectious Diseases , by Region USD Million (2021-2026)
  • Table 137. Healthcare Contract Research Outsourcing Rare Diseases , by Region USD Million (2021-2026)
  • Table 138. Healthcare Contract Research Outsourcing Medical Devices , by Region USD Million (2021-2026)
  • Table 139. Healthcare Contract Research Outsourcing Other , by Region USD Million (2021-2026)
  • Table 140. South America Healthcare Contract Research Outsourcing, by Country USD Million (2021-2026)
  • Table 141. South America Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 142. South America Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 143. South America Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 144. Brazil Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 145. Brazil Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 146. Brazil Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 147. Argentina Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 148. Argentina Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 149. Argentina Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 150. Rest of South America Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 151. Rest of South America Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 152. Rest of South America Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 153. Asia Pacific Healthcare Contract Research Outsourcing, by Country USD Million (2021-2026)
  • Table 154. Asia Pacific Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 155. Asia Pacific Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 156. Asia Pacific Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 157. China Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 158. China Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 159. China Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 160. Japan Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 161. Japan Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 162. Japan Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 163. India Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 164. India Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 165. India Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 166. South Korea Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 167. South Korea Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 168. South Korea Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 169. Taiwan Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 170. Taiwan Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 171. Taiwan Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 172. Australia Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 173. Australia Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 174. Australia Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 175. Rest of Asia-Pacific Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 176. Rest of Asia-Pacific Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 177. Rest of Asia-Pacific Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 178. Europe Healthcare Contract Research Outsourcing, by Country USD Million (2021-2026)
  • Table 179. Europe Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 180. Europe Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 181. Europe Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 182. Germany Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 183. Germany Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 184. Germany Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 185. France Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 186. France Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 187. France Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 188. Italy Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 189. Italy Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 190. Italy Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 191. United Kingdom Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 192. United Kingdom Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 193. United Kingdom Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 194. Netherlands Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 195. Netherlands Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 196. Netherlands Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 197. Rest of Europe Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 198. Rest of Europe Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 199. Rest of Europe Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 200. MEA Healthcare Contract Research Outsourcing, by Country USD Million (2021-2026)
  • Table 201. MEA Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 202. MEA Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 203. MEA Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 204. Middle East Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 205. Middle East Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 206. Middle East Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 207. Africa Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 208. Africa Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 209. Africa Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 210. North America Healthcare Contract Research Outsourcing, by Country USD Million (2021-2026)
  • Table 211. North America Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 212. North America Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 213. North America Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 214. United States Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 215. United States Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 216. United States Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 217. Canada Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 218. Canada Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 219. Canada Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 220. Mexico Healthcare Contract Research Outsourcing, by Service USD Million (2021-2026)
  • Table 221. Mexico Healthcare Contract Research Outsourcing, by End User USD Million (2021-2026)
  • Table 222. Mexico Healthcare Contract Research Outsourcing, by Therapeutic Area USD Million (2021-2026)
  • Table 223. Research Programs/Design for This Report
  • Table 224. Key Data Information from Secondary Sources
  • Table 225. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare Contract Research Outsourcing: by Service USD Million (2015-2020)
  • Figure 5. Global Healthcare Contract Research Outsourcing: by End User USD Million (2015-2020)
  • Figure 6. Global Healthcare Contract Research Outsourcing: by Therapeutic Area USD Million (2015-2020)
  • Figure 7. South America Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 8. Asia Pacific Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 9. Europe Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 10. MEA Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 11. North America Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 12. Global Healthcare Contract Research Outsourcing share by Players 2020 (%)
  • Figure 13. Global Healthcare Contract Research Outsourcing share by Players (Top 3) 2020(%)
  • Figure 14. Global Healthcare Contract Research Outsourcing share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Syneos Health (United States) Revenue, Net Income and Gross profit
  • Figure 17. Syneos Health (United States) Revenue: by Geography 2020
  • Figure 18. PAREXEL International (United States) Revenue, Net Income and Gross profit
  • Figure 19. PAREXEL International (United States) Revenue: by Geography 2020
  • Figure 20. ICON Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 21. ICON Plc (Ireland) Revenue: by Geography 2020
  • Figure 22. PRA Health Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. PRA Health Sciences, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Charles River Laboratories (United States) Revenue: by Geography 2020
  • Figure 26. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 27. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2020
  • Figure 28. IQVIA (United States) Revenue, Net Income and Gross profit
  • Figure 29. IQVIA (United States) Revenue: by Geography 2020
  • Figure 30. Medpace (United States) Revenue, Net Income and Gross profit
  • Figure 31. Medpace (United States) Revenue: by Geography 2020
  • Figure 32. Pharmaceutical Product Development, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 33. Pharmaceutical Product Development, LLC (United States) Revenue: by Geography 2020
  • Figure 34. Envigo (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Envigo (United Kingdom) Revenue: by Geography 2020
  • Figure 36. Global Healthcare Contract Research Outsourcing: by Service USD Million (2021-2026)
  • Figure 37. Global Healthcare Contract Research Outsourcing: by End User USD Million (2021-2026)
  • Figure 38. Global Healthcare Contract Research Outsourcing: by Therapeutic Area USD Million (2021-2026)
  • Figure 39. South America Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 40. Asia Pacific Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 41. Europe Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 42. MEA Healthcare Contract Research Outsourcing Share (%), by Country
  • Figure 43. North America Healthcare Contract Research Outsourcing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Syneos Health (United States)
  • PAREXEL International (United States)
  • ICON Plc (Ireland)
  • PRA Health Sciences, Inc. (United States)
  • Charles River Laboratories (United States)
  • Laboratory Corporation of America Holdings (United States)
  • IQVIA (United States)
  • Medpace (United States)
  • Pharmaceutical Product Development, LLC (United States)
  • Envigo (United Kingdom)
Additional players considered in the study are as follows:
GVK Biosciences Private Limited (India) , Pharmaron (China) , Medidata Solutions, Inc. (United States)
Select User Access Type

Key Highlights of Report


Oct 2021 240 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Healthcare Contract Research Outsourcing Market Quantitative research analysis
Global Healthcare Contract Research Outsourcing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Healthcare Contract Research Outsourcing Market are Syneos Health (United States), PAREXEL International (United States), ICON Plc (Ireland), PRA Health Sciences, Inc. (United States), Charles River Laboratories (United States), Laboratory Corporation of America Holdings (United States), IQVIA (United States), Medpace (United States), Pharmaceutical Product Development, LLC (United States) and Envigo (United Kingdom) etc.
It is a trend for pharmaceutical enterprises to contract third parties to conduct their clinical trials in order to test their drugs. This trend is stated to as ‘outsourcing’, and the companies that carry out the work are known as ‘contract research organizations’ (CROs). Furthermore, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low and middle income nations. This trend is also called ‘offshoring’. It is widely established that the offshoring of clinical trials to these regions should be examined from an ethical perspective because of the vulnerability of the trial population.

Know More About Global Healthcare Contract Research Outsourcing Market Report?

Have a Query? Click Here

Other Related Reports

Private Healthcare Comprehensive Study by Application (Hospitals, Pharmaceutical Industries, Medical Devices, Health Insurance, Medical Devices and Equipment, Others), Services (Curative, Preventive,...
$ 3350
Rickets Treatment Comprehensive Study by Type (Vitamin D-Related Rickets, Minerals Related Rickets), End User (Hospital, Clinics) Players and Region - Global Market Outlook to 2026
$ 3500
Small Joint Replacement Comprehensive Study by Type (Ankle Replacement, Digits Replacement, Elbow Replacement, Wrist Replacement), Application (Hospitals, Orthopedic Centers, Ambulatory Surgery Cente...
$ 3350
Medical Imaging Informatics Comprehensive Study by Type (Digital Radiography, Ultrasound, MRI, CT, Nuclear Imaging, Mammography), Energy Sources (Light, X-rays, Ultrasound, Nuclear Magnetic Resonance...
$ 3750
Medical Image Exchange Systems Comprehensive Study by Type (Web-Based Service, Cloud-Based Solution, Mobile-Enabled Service), Application (Hospitals, Diagnostic Centers, Educational Institutes, Clini...
$ 3350
Medical Commode Comprehensive Study by Type (Steel Commode, Aluminium Commode, Others), Application (Hospitals, Clinics, Others), Commode Type (Bedside Commode, Drop Arm Commode, Padded Commode, Bari...
$ 3750